Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternating Denosumab and Zoledronic Acid for Osteoporosis
NCT05091086Phase 4Active, not recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in osteoporosis, sponsored by National Taiwan University Hospital. Started Nov 2021; status: active, not recruiting.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05091086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05091086.